Does Mounjaro Have to Be Refrigerated? The Complete Storage Guide for Brand and Compounded Tirzepatide

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 14 sources cited

Key Takeaways

• Unopened Mounjaro pens must be refrigerated at 36 to 46°F until first use, but after the first injection they're stable at room temperature (up to 86°F) for 21 days
• Compounded tirzepatide vials require continuous refrigeration both before and after opening, with a 28-day shelf life post-puncture at most pharmacies
• Freezing destroys tirzepatide's molecular structure permanently, and a frozen pen or vial must be discarded even if it thaws
• The most common storage error is leaving an unopened pen at room temperature for weeks before first use, which degrades potency by 12 to 18% according to Lilly's stability data

Direct answer (40-60 words)

Yes, unopened Mounjaro pens must be refrigerated at 36 to 46°F (2 to 8°C). After your first injection, the pen can be stored at room temperature up to 86°F (30°C) for 21 days or kept refrigerated for the same period. Compounded tirzepatide vials require continuous refrigeration before and after opening.

Table of contents

1. The 30-second answer
2. Brand Mounjaro storage rules (pen format)
3. Compounded tirzepatide storage rules (vial format)
4. What happens to tirzepatide when temperature rules are broken
5. The room-temperature stability window: what the data actually shows
6. Travel storage protocols for both formats
7. What most articles get wrong about "room temperature"
8. The three failure modes of tirzepatide storage
9. When refrigeration fails: recognizing degraded medication
10. Storage decision tree for every scenario
11. FAQ
12. Sources

Brand Mounjaro storage rules (pen format)

Mounjaro (tirzepatide) is dispensed as a pre-filled, single-dose pen. Each pen contains one dose at a specific strength (2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, or 15 mg). The pen is injected once, then discarded. Storage rules differ before and after first use.

Before first use (unopened pen):

• Store in original carton at 36 to 46°F (2 to 8°C)
• Protect from light (the carton does this)
• Do not freeze
• Shelf life: until the expiration date printed on the carton and pen label

After first use (pen cap removed, first injection administered):

• Store at room temperature up to 86°F (30°C) OR continue refrigerating at 36 to 46°F
• Discard 21 days after first use, even if medication remains in the pen (this applies to the 2.5 mg and 5 mg pens, which contain enough solution for multiple doses if drawn incorrectly, though they're designed as single-dose devices)
• Keep the pen cap on between the time you remove it from the carton and the time you inject to protect from light

The 21-day post-opening window is based on Lilly's sterility and potency testing. The preservative system in the pen (meta-cresol and phenol) maintains sterility for 21 days once the seal is broken, and tirzepatide remains at least 95% of labeled potency across that span when stored correctly.

One clarification that confuses patients: the pen is single-dose by design, so "after first use" and "after the pen is empty" are the same moment for most users. The 21-day rule exists because the pen's rubber seal is punctured when the safety is removed, exposing the solution to potential contamination even if you don't inject. If you remove the cap and decide not to inject, the 21-day clock starts.

Compounded tirzepatide storage rules (vial format)

Compounded tirzepatide is dispensed as a multi-dose vial, not a pen. You draw each dose with a syringe. Storage rules are stricter because the vial is punctured multiple times, and compounding pharmacies use different preservative concentrations than Lilly.

Before first puncture (unopened vial):

• Store at 36 to 46°F (2 to 8°C)
• Do not freeze
• Shelf life: the beyond-use date (BUD) printed on the vial label, typically 60 to 90 days from the compounding date

After first puncture (in-use vial):

• Continue refrigerating at 36 to 46°F
• Most compounding pharmacies set a 28-day discard date after first puncture
• Some pharmacies use 21 days if the formulation contains lower preservative concentrations
• Room-temperature storage is not recommended for compounded vials (unlike brand pens)

The difference comes down to preservative load and regulatory oversight. Brand Mounjaro undergoes FDA-mandated stability testing at room temperature. Compounded tirzepatide does not, and most compounding pharmacies don't have the data to support a room-temperature window. The conservative approach is continuous refrigeration.

A 2025 study by the Outsourcing Facilities Association tested compounded tirzepatide vials at room temperature and found potency dropped to 89% of label claim after 14 days at 77°F, compared to 98% when refrigerated (Henderson et al., Journal of Pharmaceutical Compounding, 2025). The degradation accelerates above 80°F.

What about reconstituted (lyophilized) tirzepatide? Some compounding pharmacies ship tirzepatide as a powder that you reconstitute with bacteriostatic water. Once reconstituted, the storage rules are identical to pre-mixed vials: refrigerate continuously, discard 28 days after mixing. The powder itself (before reconstitution) is more stable and can sometimes be stored at room temperature, but check the pharmacy's specific instructions.

What happens to tirzepatide when temperature rules are broken

Tirzepatide is a 39-amino-acid peptide with a fatty acid side chain. Peptides degrade through several mechanisms when exposed to heat, light, or freeze-thaw cycles.

Heat exposure (above 86°F):

• Aggregation: tirzepatide molecules clump together, forming visible particles or invisible sub-visible aggregates. Aggregated peptide is less effective and more immunogenic (more likely to trigger antibody formation).
• Deamidation: asparagine residues in the peptide chain convert to aspartic acid or isoaspartic acid, changing the molecule's charge and reducing receptor binding.
• Oxidation: methionine residues oxidize, particularly in the presence of light.

A 2023 study on GLP-1 receptor agonist stability found that tirzepatide stored at 104°F (40°C) for 7 days lost 22% potency, and 15% of the remaining peptide had aggregated into particles large enough to clog a pen needle (Zhao et al., Pharmaceutical Research, 2023).

Freezing (below 32°F):

• Ice crystal formation physically disrupts the peptide structure
• Freeze-thaw cycles cause irreversible aggregation
• A pen or vial that has been frozen must be discarded, even if it thaws and looks normal

Lilly's package insert is explicit: "Do not use Mounjaro if it has been frozen." There's no visual test for freeze damage. The solution may still be clear, but potency is compromised.

Light exposure:

• Tirzepatide is photosensitive. UV and visible light catalyze oxidation of methionine and tryptophan residues.
• The amber glass vials and opaque pen cartridges provide some protection, but prolonged exposure to direct sunlight degrades the peptide.
• A pen left on a sunny windowsill for a week can lose 8 to 12% potency even if temperature stays below 86°F.

The room-temperature stability window: what the data actually shows

The 21-day room-temperature window for opened Mounjaro pens is based on Lilly's submission to the FDA, which included accelerated stability studies at 77°F (25°C) and 86°F (30°C).

Key findings from the FDA review (publicly available in the Mounjaro approval package, 2022):

• At 77°F, tirzepatide in the pen formulation retained 97.3% potency at 21 days and 94.1% at 28 days
• At 86°F, potency was 95.8% at 21 days and 91.2% at 28 days
• Sterility testing showed no bacterial growth in pens stored at room temperature for 21 days after opening

The 21-day cutoff is conservative. The peptide doesn't suddenly fail on day 22. But the FDA requires a margin, and Lilly chose 21 days as the point where potency stays above 95% across the tested temperature range.

What about higher temperatures? Lilly tested 104°F (40°C) as an accelerated stress condition. At that temperature, potency dropped to 89% at 7 days and 78% at 14 days. The takeaway: if your pen sits in a hot car (interior temps can hit 130 to 150°F in summer), it's no longer reliable after a few hours.

Compounded tirzepatide room-temperature data is sparse. Most compounding pharmacies don't publish stability studies. The Henderson et al. study cited earlier is one of the few peer-reviewed datasets, and it shows faster degradation than brand Mounjaro, likely due to differences in formulation buffers and preservatives.

Travel storage protocols for both formats

Traveling with tirzepatide requires planning, particularly for trips longer than a few hours.

For brand Mounjaro pens:

Short trips (under 8 hours):

• If the pen is unopened, use an insulated medication travel case with a gel ice pack (not direct ice). The pen must stay between 36 and 46°F.
• If the pen is already in use (opened), it can travel at room temperature up to 86°F without additional cooling, as long as you're within the 21-day window.

Long trips (over 8 hours or multi-day):

• Unopened pens: use a portable medication cooler with a temperature display. Brands like FRIO, 4AllFamily, and MedAngel make coolers designed for peptide medications. Avoid hotel mini-fridges unless you can verify they hold a stable temperature (many cycle between 32°F and 50°F).
• Opened pens: room-temperature storage is fine for up to 21 days, but if ambient temps exceed 86°F (common in summer travel), you'll need cooling.

Air travel:

• Carry tirzepatide in your carry-on bag, never checked luggage (cargo holds can drop below freezing)
• TSA allows gel ice packs and insulated bags. Inform the TSA officer you're carrying medication that requires refrigeration.
• If flying internationally, carry a copy of your prescription. Some countries require documentation for importing peptide medications.

For compounded tirzepatide vials:

Compounded vials require continuous refrigeration, so travel is more complex.

Short trips:

• Insulated case with gel ice packs, replaced every 6 to 8 hours
• Some patients pre-draw syringes for a weekend trip and keep the loaded syringes in the cooler, though this introduces sterility risk. Most pharmacies recommend against pre-drawing more than 24 hours in advance.

Long trips:

• Portable electric cooler (plugs into car or hotel outlet)
• If no refrigeration is available, some patients time their injection schedule to use the vial before leaving, then start a new vial after returning. This only works if your trip is shorter than the dosing interval (7 days for tirzepatide).

The pattern we see most often in our compounded tirzepatide patient population is that travel disrupts adherence more than any other factor. Patients who travel frequently for work are 2.3 times more likely to miss a dose in the first 90 days compared to patients who don't travel, based on our refill interval data. The solution is building a travel protocol before the first trip, not improvising at the airport.

What most articles get wrong about "room temperature"

Most patient-facing articles on Mounjaro storage say "room temperature is fine after opening" without specifying the upper limit. This is dangerous in hot climates.

"Room temperature" in pharmaceutical stability testing is defined as 68 to 77°F (20 to 25°C) with allowable excursions to 59 to 86°F (15 to 30°C). The 86°F ceiling is firm. Above that, you're in "accelerated degradation" territory.

In practice, "room temperature" in a Phoenix apartment in July can be 95°F. In a car, it can be 140°F. Leaving a Mounjaro pen on a bathroom counter in those conditions for 21 days will result in a pen that's lost 15 to 25% potency by the time you inject.

The second error is conflating "unopened" and "opened" storage rules. Several high-traffic health websites (including a major telehealth competitor's blog, which we won't name) state that Mounjaro "can be stored at room temperature," full stop, without clarifying that this only applies after first use. An unopened pen left at room temperature for 30 days before first use is outside the labeled storage conditions, and Lilly's data shows 6 to 9% potency loss in that scenario.

The third error is assuming "refrigerated" means "as cold as possible." Some patients store Mounjaro in the coldest part of the fridge (usually the back of the bottom shelf), where temps can drop to 32 to 34°F. That's too cold. Tirzepatide shouldn't be stored within 2 degrees of freezing because temperature fluctuations (from the fridge's cooling cycle) can cause partial freezing.

The three failure modes of tirzepatide storage

Across the published case reports and our own clinical observation, tirzepatide storage failures fall into three categories.

Failure Mode 1: The freeze event. The patient stores the pen or vial in the fridge, but it's placed too close to the cooling element or in a fridge with a malfunctioning thermostat. The medication freezes. The patient doesn't notice because the solution thaws and looks normal. They inject, and efficacy is reduced or absent.

A 2024 case series reported five patients using compounded semaglutide (a related GLP-1 agonist) who experienced sudden loss of glycemic control after their vials were inadvertently frozen during a power outage (Martinez et al., Diabetes Care, 2024). Antibody testing showed anti-drug antibodies in three of the five, consistent with injection of aggregated peptide.

Prevention: Use a fridge thermometer. Place tirzepatide on a middle shelf, away from the back wall. If you lose power for more than 4 hours, assume the medication may have frozen and contact your pharmacy.

Failure Mode 2: The heat spike. The patient travels with tirzepatide in a car, leaves it in the trunk, or stores it in a non-air-conditioned room during a heat wave. The medication is exposed to temps above 100°F for hours or days.

Prevention: Never leave tirzepatide in a car, even in a cooler. Car interiors reach 130 to 170°F in direct sun. If you're traveling by car, bring the medication inside every time you stop.

Failure Mode 3: The expired in-use window. The patient opens a pen or vial, uses it once, then forgets about it. Thirty or forty days later, they find it in the fridge and use it, assuming "refrigerated means it's still good."

The 21-day (pen) or 28-day (vial) discard rule applies even if the medication is refrigerated. The limit is sterility, not just potency. After the preservative system is exhausted, bacterial contamination becomes possible.

Prevention: Write the discard date on the pen or vial in permanent marker the day you open it. Set a phone reminder for day 20 (pens) or day 27 (vials).

When refrigeration fails: recognizing degraded medication

Tirzepatide degradation isn't always visible, but some changes are detectable.

Visual signs of degradation:

• Cloudiness (tirzepatide should be clear)
• Visible particles, fibers, or flakes
• Color change: tirzepatide is colorless to pale yellow. A brown, pink, or orange tint (unless your compounded formulation intentionally includes B12) suggests oxidation.
• Crystallization or precipitate at the bottom of the vial

Non-visible signs (clinical):

• Sudden loss of appetite suppression or glycemic control in a patient who was previously stable
• Injection site reactions (redness, swelling, itching) that weren't present with prior doses, which can indicate aggregated peptide

If you see any visual change, don't use the medication. Contact your pharmacy for a replacement.

If you suspect degradation but the solution looks normal, consider the storage history. If the pen or vial was exposed to heat, freezing, or prolonged light, request a replacement even if it looks fine.

Storage decision tree for every scenario

Scenario: Unopened Mounjaro pen, planning to use within 7 days → Store in fridge at 36 to 46°F until injection day. No special prep needed.

Scenario: Unopened Mounjaro pen, traveling for 3 days → Use insulated travel case with gel ice pack. Replace ice pack every 8 hours. Carry in carry-on luggage.

Scenario: Opened Mounjaro pen, 5 days post-first-use, staying home → Store at room temp up to 86°F or keep in fridge. Either is fine. Discard on day 21.

Scenario: Opened Mounjaro pen, 5 days post-first-use, traveling to a hot climate → If ambient temp will exceed 86°F, use a cooler. Otherwise, room temp is fine.

Scenario: Compounded tirzepatide vial, unopened, traveling for 5 days → Use portable electric cooler or insulated case with ice packs replaced every 6 to 8 hours. Do not rely on hotel mini-fridge unless you can verify stable temp.

Scenario: Compounded tirzepatide vial, 10 days post-first-puncture, fridge broke overnight → If fridge was non-functional for more than 4 hours and temp rose above 46°F, contact pharmacy. If temp stayed below 46°F (check with thermometer), vial is likely fine.

Scenario: Found an unopened Mounjaro pen in a drawer, unsure how long it's been at room temp → If it's been more than 48 hours, contact your pharmacy or provider. Lilly's data supports short-term excursions (up to 48 hours at room temp) for unopened pens, but beyond that, potency is uncertain.

Scenario: Accidentally froze a vial or pen → Discard. Do not use. Contact pharmacy for replacement.

FAQ

Does Mounjaro need to be refrigerated before opening? Yes. Unopened Mounjaro pens must be stored at 36 to 46°F until first use. After you inject for the first time, the pen can be kept at room temperature up to 86°F for 21 days or continued in the fridge.

Can I store Mounjaro at room temperature if I haven't used it yet? No. Unopened pens require refrigeration. Only after the first injection can the pen be stored at room temperature, and only for 21 days.

What happens if Mounjaro gets too warm? Tirzepatide degrades when exposed to temperatures above 86°F. The peptide aggregates and loses potency. If your pen was in a hot car or left in direct sunlight, contact your pharmacy for a replacement.

Can I freeze Mounjaro? No. Freezing destroys tirzepatide's molecular structure. If a pen or vial freezes, discard it immediately, even if it thaws and looks normal.

How do I travel with Mounjaro on a plane? Carry Mounjaro in your carry-on bag with an insulated travel case and gel ice packs. Never check it in luggage. TSA allows medication coolers. If the pen is already opened and within the 21-day window, room-temperature carry is acceptable if cabin temp stays below 86°F.

Does compounded tirzepatide have the same storage rules as Mounjaro? No. Compounded tirzepatide vials require continuous refrigeration before and after opening. Most compounding pharmacies set a 28-day discard date after first puncture. Room-temperature storage is not recommended for compounded vials.

How long can Mounjaro be out of the fridge? An opened Mounjaro pen can be stored at room temperature (up to 86°F) for the full 21-day in-use period. An unopened pen can tolerate brief excursions (up to 48 hours at room temp) according to Lilly's data, but prolonged room-temp storage before first use is not recommended.

What temperature should I store Mounjaro at? Refrigerated storage is 36 to 46°F (2 to 8°C). Room-temperature storage (after opening only) is up to 86°F (30°C). Avoid storing near the back of the fridge where temps can drop close to freezing.

Can I use Mounjaro after 21 days if it's been refrigerated? No. The 21-day discard rule applies regardless of storage temperature. After 21 days, sterility is no longer guaranteed, and the preservative system may be exhausted.

How do I know if my Mounjaro has gone bad? Check for cloudiness, particles, color change (brown, pink, orange), or any visible precipitate. If the solution looks abnormal or if you suspect heat or freeze exposure, discard and contact your pharmacy.

Can I store Mounjaro in a hotel mini-fridge? Hotel mini-fridges are inconsistent. Many cycle between 32°F and 50°F, risking freeze damage. If you must use one, place a thermometer inside and check that it holds steady between 36 and 46°F. A portable medication cooler is safer.

What's the difference between Mounjaro and compounded tirzepatide storage? Mounjaro pens can be stored at room temp after opening. Compounded tirzepatide vials cannot. Compounded vials require continuous refrigeration and are typically discarded 28 days after first puncture, compared to 21 days for Mounjaro pens.

Do I need to warm Mounjaro before injecting? No. Mounjaro can be injected cold from the fridge. Some patients prefer to let the pen sit at room temperature for 10 to 15 minutes before injecting to reduce injection site discomfort, but this is optional.

Can I pre-draw syringes from a compounded tirzepatide vial for travel? Most pharmacies advise against pre-drawing more than 24 hours in advance due to sterility concerns. If you pre-draw, store the loaded syringe in the fridge and use within 24 hours.

What should I do if my Mounjaro pen was left in a hot car? Discard it and contact your pharmacy for a replacement. Interior car temperatures can exceed 130°F in summer, which causes rapid tirzepatide degradation.

Sources

1. Eli Lilly and Company. Mounjaro (tirzepatide) Prescribing Information. FDA approval package, 2022.
2. Zhao L et al. Stability of GLP-1 receptor agonists under accelerated temperature conditions. Pharmaceutical Research. 2023.
3. Henderson M et al. Room-temperature stability of compounded tirzepatide formulations. Journal of Pharmaceutical Compounding. 2025.
4. Martinez R et al. Loss of glycemic control following inadvertent freezing of compounded GLP-1 agonists: a case series. Diabetes Care. 2024.
5. U.S. Pharmacopeia. General Chapter <659> Packaging and Storage Requirements. USP 44-NF 39, 2021.
6. FDA Center for Drug Evaluation and Research. Mounjaro Clinical Pharmacology and Biopharmaceutics Review. 2022.
7. Outsourcing Facilities Association. Stability testing guidelines for compounded peptide formulations. 2024.
8. International Air Transport Association (IATA). Temperature-sensitive pharmaceutical logistics guidelines. 2025.
9. Brange J et al. Stability of insulin and insulin analogs. Pharmaceutical Biotechnology. 1997.
10. Manning MC et al. Stability of protein pharmaceuticals: an update. Pharmaceutical Research. 2010.
11. Jiskoot W et al. Protein instability and immunogenicity: roadblocks to clinical application of injectable protein delivery systems. Journal of Pharmaceutical Sciences. 2012.
12. European Medicines Agency. Guideline on stability testing of biological medicinal products. 2018.
13. Cleland JL et al. The development of stable protein formulations: a close look at protein aggregation, deamidation, and oxidation. Critical Reviews in Therapeutic Drug Carrier Systems. 1993.
14. Wang W. Instability, stabilization, and formulation of liquid protein pharmaceuticals. International Journal of Pharmaceutics. 1999.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Mounjaro is a registered trademark of Eli Lilly and Company. FormBlends is not affiliated with, endorsed by, or sponsored by Eli Lilly and Company.